| Symbol | OBIO |
|---|---|
| Name | ORCHESTRA BIOMED HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 150 UNION SQUARE DRIVE, NEW HOPE, Pennsylvania, 18938, United States |
| Telephone | +1 215 - 862-5797 |
| Fax | — |
| — | |
| Website | https://www.orchestrabiomed.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001814114 |
| Description | Orchestra BioMed Holdings, Inc. is a biomedical innovation company. Its lead product candidate is BackBeat Cardiac Neuromodulation Therapy (BackBeat CNT) for the treatment of hypertension (HTN), the leading risk factor for death worldwide. It is also developing the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. It is developing bioelectronic therapies based on patented CNT technology. BackBeat CNT, also known as Atrioventricular Interval Modulation (AVIM) therapy, is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant. Additional info from NASDAQ: |
Taylor Andrew Lawrence 🔴 sold 36.4K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $4.02 Transaction Date: Jun 10, 2026 | Filing ID: 073476
Read moreDirector Hochman David P 🔴 sold 6.6K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $4.02 Transaction Date: Jun 10, 2026 | Filing ID: 073468
Read moreDirector Hochman David P 🟢 acquired 5.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.83 Transaction Date: Jun 01, 2026 | Filing ID: 069510
Read moreDirector Sherman Darren 🔴 sold 15.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.87 Transaction Date: Jun 01, 2026 | Filing ID: 069503
Read moreOrchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more📋 Sherman Darren (Officer) plans to sell 15K shares of Orchestra BioMed Holdings, Inc. (at $3.87 each, total $58K) Filed: Jun 01, 2026 | ID: 004222
Read moreTaylor Andrew Lawrence 🔴 sold 3.1K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.98 Transaction Date: May 28, 2026 | Filing ID: 068278
Read moreDirector Aryeh Jason 🟢 acquired 665 shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.75 Transaction Date: May 18, 2026 | Filing ID: 064136
Read moreOrchestra BioMed to Participate in the Jefferies Global Healthcare Conference
Read moreDirector Aryeh Jason 🟢 acquired 9.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $3.90 Transaction Date: May 15, 2026 | Filing ID: 063511
Read more